Clinical Trial Update: The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis [Phase 3]

View source ↗

Summary

Phase III trial of X842 Capsules for Reflux Esophagitis has completed, according to the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• X842 Capsules

Snippet

Sponsor: Jiangsu Sinorda Biomedicine Co., Ltd | Conditions: Reflux Esophagitis | Phase 3 | Status: COMPLETED